| Price | 1,298.00p on 12-06-2026 at 18:25:11 |
|---|---|
| Change | 36.00p 2.85% |
| Buy | 1,300.00p |
| Sell | 1,292.00p |
| Last Trade: | Unknown 32,961.00 at 1,237.04p |
| Day's Volume: | 59,379 |
| Last Close: | 1,298.00p |
| Open: | 1,260.00p |
| ISIN: | GB0000385517 |
| Day's Range | 1,260.00p - 1,300.00p |
| 52wk Range: | 702.00p - 1,374.00p |
| Market Capitalisation: | £251.12m |
| VWAP: | 1,255.61234p |
| Shares in Issue: | 19.35m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Biotech Gwth (BIOG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 32,961 | 1,237.04p | Negotiated Trade |
16:39:53 - 12-Jun-26 |
| Sell* | 2,687 | 1,298.00p | Uncrossing Trade |
16:35:29 - 12-Jun-26 |
| Buy* | 67 | 1,300.00p | Automatic Execution |
16:25:28 - 12-Jun-26 |
| Buy* | 200 | 1,300.00p | Automatic Execution |
16:25:28 - 12-Jun-26 |
| Sell* | 1 | 1,294.00p | Automatic Execution |
16:22:32 - 12-Jun-26 |
| Sell* | 25 | 1,294.00p | Automatic Execution |
16:22:07 - 12-Jun-26 |
| Sell* | 30 | 1,294.00p | Automatic Execution |
16:22:07 - 12-Jun-26 |
| Sell* | 3 | 1,294.00p | SI Trade |
16:17:36 - 12-Jun-26 |
| Unknown* | 0 | 1,296.00p | SI Trade |
16:09:05 - 12-Jun-26 |
| Buy* | 863 | 1,298.00p | Automatic Execution |
16:09:05 - 12-Jun-26 |
Biotech Gwth (BIOG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 12th Jun 2026 5:39 pm | PRN | Transaction in Own Shares |
| 12th Jun 2026 3:48 pm | PRN | Net Asset Value(s) |
| 11th Jun 2026 1:32 pm | PRN | Net Asset Value(s) |
| 10th Jun 2026 3:07 pm | PRN | Monthly Fact Sheet as at 31 May 2026 |
| 10th Jun 2026 1:33 pm | PRN | Net Asset Value(s) |
| 9th Jun 2026 1:57 pm | PRN | GSK plc to acquire BIOG portfolio company, Nuvalent, Inc. |
| 9th Jun 2026 12:47 pm | PRN | Net Asset Value(s) |
| 8th Jun 2026 1:58 pm | PRN | Net Asset Value(s) |
| 5th Jun 2026 5:29 pm | PRN | Transaction in Own Shares |
| 5th Jun 2026 2:57 pm | PRN | Net Asset Value(s) |
